BiotechTube
Home/Kinoxis Therapeutics/Hugh Alsop
HA

Hugh Alsop

Chief Executive Officer

Kinoxis Therapeutics

Therapeutic Areas

Central Nervous SystemPainSubstance Use Disorder

Kinoxis Therapeutics Pipeline

DrugIndicationPhase
KNX100Agitation and aggression associated with dementiaPhase 2
KNX101Acute and chronic painPreclinical/IND‑enabling
KNX200 seriesStress adaptation, emotional regulation, nociception (oxytocin‑receptor partial agonists)Preclinical

Leadership Team at Kinoxis Therapeutics

MB
Michael Bowen
Chief Scientific Officer
TA
Tiina Ahveninen
Vice President, Clinical Research
TR
Tristan Reekie
Head of Chemistry
CJ
Cameron Jones
Chief Financial Officer & Company Secretary
PD
Peter Devine
Chair
JC
Julie Cairney
Non‑Executive Director
KN
Kathy Nielsen
Non‑Executive Director
View full Kinoxis Therapeutics profile